NCT06074705View on ClinicalTrials.gov

A Study of DS-1471a In Subjects With Advanced Solid Tumors

PHASE1TerminatedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

August 4, 2023

Primary Completion Date

July 29, 2025

Study Completion Date

July 29, 2025

Conditions
Advanced Solid Tumor
Interventions
DRUG

DS-1471a

Intravenous administration on Day 1 of each 28-day cycle

Trial Locations (5)

34236

Florida Cancer Specialist, Sarasota

53226

Medical College of Wisconsin, Milwaukee

277-8577

National Cancer Center Hospital East, Chiba

104-0045

National Cancer Center Hospital, Tokyo

135-8550

The Cancer Institute Hospital of JFCR, Tokyo

Sponsors
All Listed Sponsors
lead

Daiichi Sankyo Co., Ltd.

INDUSTRY

NCT06074705 - A Study of DS-1471a In Subjects With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter